ZNTL
Zentalis Pharmaceuticals Llc
2.50$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,827.8% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +50.6% | +15.1% | +52.6% | +64.6% | +1.2% | +7.8% | -4.3% | +0.3% | -4.4% | +1.2% | -3.2% | -3.9% | +0.9% | -1.8% | -1.2% | -17.4% | -38.9% | – | – | -3.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,177.1% | -100.8% | – | – | -101.0% | – | – | – | – | – | – | |
| – | +22.6% | +23.6% | +10.5% | +11.7% | +31.6% | +41.4% | +19.7% | +30.1% | +16.6% | +20.6% | -28.8% | +20.0% | -5.0% | -3.8% | -3.7% | +19.6% | -12.1% | +9.6% | +10.2% | -3.8% | -2.4% | -23.9% | -10.5% | -17.4% | +1.3% | -16.9% | +28.5% | -2.6% | +122.5% | – | |
| – | +19.2% | -5.2% | +64.6% | +3.5% | +216.0% | +1.7% | +6.2% | +11.5% | -13.3% | -14.4% | +9.9% | +20.6% | +66.9% | -38.8% | -7.3% | +47.0% | -4.3% | +1.8% | +2.6% | -3.8% | +6.5% | -12.9% | +173.9% | -73.6% | -31.0% | +47.8% | -26.7% | +15.6% | +101.0% | – | |
| – | +21.9% | +18.3% | +18.5% | +10.0% | +66.9% | +27.0% | +15.8% | +25.1% | +9.5% | +14.0% | -23.3% | +20.1% | +9.6% | -14.6% | -4.5% | +25.5% | +60.0% | -39.6% | +8.3% | -4.3% | +0.2% | -21.1% | +49.2% | -40.5% | -21.0% | -6.4% | +10.8% | +0.8% | +118.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -12.8% | – | – | – | -58.8% | +502.8% | -91.8% | -5.5% | +1,624.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -964.3% | – | – | – | – | – | – | – | – | – | |
| – | +266.7% | -90.9% | -53,900.0% | – | – | – | +2,266.7% | -54.0% | -77.0% | -1,648.9% | – | -79.2% | -48.5% | -1,035.3% | – | – | -660.2% | – | -535.5% | – | +86.0% | -110.2% | – | – | – | – | – | -72.9% | +115.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -976.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -934.5% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.